Volume Spike Investor

Shares of TomoTherapy Inc. (NASDAQ: TOMO) are being squashed this morning after its earnings report.  Its results were under plan and the current economic environment is hurting the company’s performance on softness in new orders.  This means that hospitals are still feeling the pinch from donations and elsewhere because this company makes radiation therapy systems for treating cancer.

Wall Street hates when medical companies say that the economy is hurting their results since so many treat this with a near-immune status.  To prove the point, share are down some 46% on over 4.1 million shares. This normally trades about 500,000 shares per day.

This stock does have stock options that trade in the stock, but they are very illiquid.  At $5.20, this is a new low under the 52-week trading range of $6.79 to $26.80.

JON OGG

AUG. 1, 2008 (10:30 AM EST)